Cargando…

Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer

HPV infrequently persists and progresses to cervical cancer. We examined host genetic factors hypothesized to play a role in determining which subset of individuals infected with oncogenic human papillomavirus (HPV) have persistent infection and further develop cervical pre-cancer/cancer compared to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Sophia S., Gonzalez, Paula, Yu, Kai, Porras, Carolina, Li, Qizhai, Safaeian, Mahboobeh, Rodriguez, Ana Cecilia, Sherman, Mark E., Bratti, Concepcion, Schiffman, Mark, Wacholder, Sholom, Burk, Robert D., Herrero, Rolando, Chanock, Stephen J., Hildesheim, Allan
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801608/ https://www.ncbi.nlm.nih.gov/pubmed/20084279 http://dx.doi.org/10.1371/journal.pone.0008667

Ejemplares similares

Single Nucleotide Polymorphisms in the PRDX3 and RPS19 and Risk of HPV Persistence and Cervical Precancer/Cancer
por: Safaeian, Mahboobeh, et al.
Publicado: (2012)

Determinants of seropositivity among HPV-16/18 DNA positive young women
por: Porras, Carolina, et al.
Publicado: (2010)

A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection
por: Clarke, Megan A, et al.
Publicado: (2012)

HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays
por: Lin, Shih-Wen, et al.
Publicado: (2013)

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
por: Kreimer, Aimée R., et al.
Publicado: (2011)

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
por: Hildesheim, Allan, et al.
Publicado: (2016)

Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials
por: Wacholder, Sholom, et al.
Publicado: (2010)

Comparison of Antibody Responses to Human Papillomavirus Vaccination as Measured by Three Assays
por: Robbins, Hilary A., et al.
Publicado: (2014)

Cervicovaginal microbiome and natural history of HPV in a longitudinal study
por: Usyk, Mykhaylo, et al.
Publicado: (2020)

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study
por: Castle, Philip E, et al.
Publicado: (2009)

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial
por: Panagiotou, Orestis A, et al.
Publicado: (2015)

Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
por: Herrero, Rolando, et al.
Publicado: (2013)

Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
por: Kreimer, Aimée R., et al.
Publicado: (2018)

A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica
por: Clarke, Megan, et al.
Publicado: (2013)

Sequence Imputation of HPV16 Genomes for Genetic Association Studies
por: Smith, Benjamin, et al.
Publicado: (2011)

Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus
por: Robbins, Hilary A, et al.
Publicado: (2014)

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica
por: Hildesheim, A, et al.
Publicado: (2001)

A case–control study of endogenous hormones and cervical cancer
por: Shields, T S, et al.
Publicado: (2004)

T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study
por: Lang Kuhs, Krystle A., et al.
Publicado: (2018)

Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70
por: Chen, Zigui, et al.
Publicado: (2013)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica
por: Wang, S S, et al.
Publicado: (2004)

Population Substructure and Control Selection in Genome-Wide Association Studies
por: Yu, Kai, et al.
Publicado: (2008)

Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels
por: Kemp, Troy J., et al.
Publicado: (2012)

A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria
por: Clarke, Megan A, et al.
Publicado: (2011)

Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial
por: Sierra, Mónica S., et al.
Publicado: (2023)

Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection
por: Cullen, Michael, et al.
Publicado: (2015)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica
por: Wang, S S, et al.
Publicado: (2003)

Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci
por: Carrington, Mary, et al.
Publicado: (2005)

Genetic Admixture and Population Substructure in Guanacaste Costa Rica
por: Wang, Zhaoming, et al.
Publicado: (2010)

The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis
por: Mirabello, Lisa, et al.
Publicado: (2018)

Excess mortality from COVID 19 in Costa Rica: a registry based study using Poisson regression
por: Fantin, Romain, et al.
Publicado: (2023)

molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history
por: Usyk, Mykhaylo, et al.
Publicado: (2022)

Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial
por: Baisley, Kathy, et al.
Publicado: (2022)

Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial
por: Wright, Thomas C., et al.
Publicado: (2021)

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
por: Bee, Katharine J., et al.
Publicado: (2021)

Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods
por: Castro, Felipe A., et al.
Publicado: (2015)

Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma
por: Safaeian, Mahboobeh, et al.
Publicado: (2014)

False positive cervical HPV screening test results
por: Schiffman, Mark, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bg8b77ase6eefc97smpv3r89bs